Eli Lilly and Co at Goldman Sachs Healthcare Conference Transcript
Okay. Let's kick off the afternoon session here. I hope everyone enjoyed the lunchtime discussion and has had a positive and productive morning so far. My name is Chris Shibutani. I'm a member of the research team.
We are thrilled to be able to present Lilly at our conference here: Anat Ashkenazi, the CFO; and also really appreciative of the entire team that's out here, the stellar IR team, Joe Fletcher, Lauren Zierke; and James Gilroy is also here, for those of you lucky enough to get into conversations, talking about market access, which is obviously extremely topical.
Questions & Answers
So many inbound questions. Obviously, the center of gravity of our conversation is very clear. One of the things that I like to do personally, however, is that since this is a conversation as well between you and me is to make sure that we understand who you are.
We spent a little bit
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
